HTX Technologies, LLC is a company dedicated to the advancement of molecular imaging technologies, with a primary focus on Mass Spectrometry Imaging. Founded in 2008, the company specializes in tissue imaging and molecular imaging technologies, with an emphasis on sample preparation and MALDI Mass Spectrometry Imaging. Their patented TM-Sprayer™ Tissue MALDI Sample Preparation System is designed to ensure high-quality MALDI matrix deposition on two-dimensional biological samples and can be integrated with any MALDI Mass Spectrometer platform. HTX emphasizes the importance of preserving valuable sample information during preparation, offering automated sample prep, workflow implementation, available instrumentation, and best practices. The company serves worldwide and can be contacted via www.htximaging.com or [email protected].
The industries HTX Technologies operates in include Biotechnology, Medical Devices, and Clean Energy. The company is currently seeking investment, with the last investment details and investors remaining undisclosed. HTX Technologies presents an innovative approach to molecular imaging and offers potential for growth and advancement in the biotechnology and medical devices sectors.
There is no investment information
No recent news or press coverage available for HTX Technologies, LLC.